Usage and dosage of Nirmatrelvir/Ritonavir combination

Paxlovid (Nirmatrelvir/Ritonavir) is a drug used to treat novel coronavirus infection in adults who do not require supplemental oxygen and are at increased risk of becoming severe. The recommended dose of nematvir/ritonavir tablet combination is 300 mg nematvir (two 150 mg tablets) and 100 mg ritonavir (one 100 mg tablet), three tablets taken orally twice daily for 5 days.

Completing the full 5-day course of treatment and continuing to isolate in accordance with public health recommendations is critical to maximize virus clearance and minimize the spread of the novel coronavirus. After diagnosis of novel coronavirus infection, the 5-day nematvir/ritonavir tablet combination treatment should be started as soon as possible. Even if the baseline novel coronavirus infection symptoms are mild, it should be started within 5 days after the onset of symptoms. If a patient requires hospitalization due to severe or critical novel coronavirus infection after starting treatment with the nematvir/ritonavir tablet combination, the patient should complete the complete 5-day treatment course according to the judgment of the medical staff.

NematrevirThe combination of nematvir/ritonavir tablets has been launched in China. Due to its short time on the market, it has not been included in the medical insurance. The domestic price has not yet been determined. The original drug of nematvir/ritonavir tablet combination marketed overseas, the specification is nematvir 150mg + ritonavir 100mg)*30 tablets per box, the price may be around 2,000 yuan (the price may fluctuate due to the exchange rate), India The price of each box of the generic Nematvir/Ritonavir tablet combination produced by the pharmaceutical factory may be around RMB 1,000 (the price may fluctuate due to the exchange rate). The ingredients of the two drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.